DiaMedica Therapeutics IPO: Results To Be Released In Q4 2019 Or Q1 2020
Minnesota-based, DiaMedica Therapeutics is a biopharmaceutical organization planning novel recombinant (engineered) proteins to treat intense ischemic stroke, ceaseless kidney malady, ...
